Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Ivan Rafael Lockward, MD, MPH
Internal Medicine · RUNNEMEDE, NJ · NPI 1922589480
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 775 | 160 |
| Metformin Hcl | Metformin Hcl | 481 | 106 |
| Lisinopril | Lisinopril | 404 | 87 |
| Gabapentin | Gabapentin | 387 | 72 |
| Famotidine | Famotidine | 382 | 67 |
| Diclofenac Sodium | Diclofenac Sodium | 357 | 76 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 332 | 60 |
| Losartan Potassium | Losartan Potassium | 314 | 61 |
| Amlodipine Besylate | Amlodipine Besylate | 300 | 77 |
| Omeprazole | Omeprazole | 260 | 55 |
| Montelukast Sodium | Montelukast Sodium | 233 | 35 |
| Metoprolol Succinate | Metoprolol Succinate | 229 | 44 |
| Levothyroxine Sodium | Levothyroxine Sodium | 221 | 36 |
| Jardiance | Empagliflozin | 216 | 48 |
| Nifedipine Er | Nifedipine | 167 | 34 |
| Fluticasone Propionate | Fluticasone Propionate | 164 | 35 |
| Trulicity | Dulaglutide | 148 | 23 |
| Januvia | Sitagliptin Phosphate | 147 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 138 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 132 | 42 |
| Alendronate Sodium | Alendronate Sodium | 123 | 21 |
| Sertraline Hcl | Sertraline Hcl | 122 | 22 |
| Trazodone Hcl | Trazodone Hcl | 121 | 21 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 119 | 20 |
| Simvastatin | Simvastatin | 115 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 115 | 28 |
| Chlorthalidone | Chlorthalidone | 103 | 19 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 89 | 15 |
| Pantoprazole Sodium | Pantoprazole Sodium | 88 | 16 |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 68 | suppressed |
| Carvedilol | Carvedilol | 66 | 24 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 66 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 62 | suppressed |
| Mirtazapine | Mirtazapine | 62 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 62 | 12 |
| Metformin Hcl Er | Metformin Hcl | 60 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 59 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 58 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 57 | suppressed |
| Valsartan | Valsartan | 56 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 55 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 48 | suppressed |
| Memantine Hcl | Memantine Hcl | 48 | suppressed |
| Allopurinol | Allopurinol | 47 | suppressed |
| Glipizide | Glipizide | 46 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 46 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 45 | 19 |
| Furosemide | Furosemide | 42 | 12 |
| Xarelto | Rivaroxaban | 42 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 41 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 41 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 40 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 40 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 39 | 11 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 38 | suppressed |
| Meloxicam | Meloxicam | 37 | 12 |
| Buspirone Hcl | Buspirone Hcl | 35 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 35 | 15 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 35 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 33 | suppressed |
| Ketoconazole | Ketoconazole | 33 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 33 | suppressed |
| Topiramate | Topiramate | 33 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 33 | suppressed |
| Ibuprofen | Ibuprofen | 32 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Sucralfate | Sucralfate | 32 | suppressed |
| Ozempic | Semaglutide | 31 | suppressed |
| Finasteride | Finasteride | 30 | suppressed |
| Lidocaine | Lidocaine | 30 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 30 | 12 |
| Advocate Pen Needles | Pen Needle, Diabetic | 28 | suppressed |
| Novolog Flexpen | Insulin Aspart | 28 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 27 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 27 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 26 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 26 | suppressed |
| Loperamide | Loperamide Hcl | 25 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 23 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 22 | suppressed |
| Glipizide Er | Glipizide | 22 | suppressed |
| Potassium Chloride | Potassium Chloride | 22 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Eliquis | Apixaban | 21 | suppressed |
| Hydrocortisone | Hydrocortisone | 21 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 20 | suppressed |
| Ezetimibe | Ezetimibe | 20 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 19 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 19 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 18 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Prezcobix | Darunavir/Cobicistat | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Valproic Acid | Valproic Acid | 14 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 13 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Levetiracetam | Levetiracetam | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Lorazepam | Lorazepam | 13 | suppressed |
| Prednisone | Prednisone | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 12 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Spironolactone | Spironolactone | 12 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
| True Comfort Safety Pen Needle | Pen Needle, Diabetic, Safety | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error